- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Global Digital Pathology Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Pathology is a significant field in the modern medical diagnosis and medical research, concerned mainly with the causal study of disease, whether caused by pathogens or non-infectious physiological disorder. Pathology includes the related scientific study of the disease process. Pathology plays a vital role in all aspects of medicine throughout our lives.
Global Digital Pathology Market Size & Growth:
The global digital pathology market was valued at $0.42 billion in 2019 and is estimated to reach $0.95 billion by 2025, at a CAGR of 13.4% during 2019-2025. The critical factors responsible for the growth of the global digital pathology market include growing trend of digitalisation in the medical sector, rising Incidence of cancer, increasing opportunities by governments and industry players and growing applications of digital pathology in drug development. The high cost of digital pathology systems, lack of reimbursement and inadequate infrastructure are hampering the market growth. The future scope of the global digital pathology market is disabling the deficiency of pathologists through digital pathology, personalised medicine, the addition of laboratory and digital pathology systems, integration of laboratory information systems (LIS) and digital pathology systems.
Global Digital Pathology Market Segments Share:
The global digital pathology market is segmented based on the type, product, application, end user and geography. By type, the global digital pathology market is segregated into human pathology, veterinary pathology. Human pathology is the largest market in the global digital pathology market owing to the factors like increasing adoption of the digital pathology to enhance lab efficiency and growing applications of digital pathology. Veterinary pathology is the promising segment tending towards the market growth. By product, the market is segregated into scanners, software, communication systems, storage systems. The software is expected to register the highest growth and is also largest market by product due to the availability of analytical, user-friendly and advanced functions for pathology diagnosis. By application, the market is categorised into teleconsultation, disease diagnosis, drug discovery, training and education. Tele-consultation is the largest market and is expected to register the fastest growth in the global pathology market owing to the increasing need for quality, and fast diagnosis have enhanced the utilisation of teleconsultation applications. By geography, North America is the most significant market share in the digital pathology market owing to increasing usage of digital pathology for disease diagnosis and favourable reimbursement policies in the U.S. for improving the quality of cancer diagnosis. Asia Pacific region is the fastest growing region due to the presence of a large target patient population, and booming healthcare industry is encouraging the growth of the regional market.
Global Digital Pathology Market Trends:
- Visiopharm has entered an agreement with HAMAMATSU to sell their portfolio of slide scanners, co-branded as Oncotopix® Scan, for clinical customers in Europe.
- Bayer develops companion diagnostic test for cancer patients together with Leica Biosystems.
Global Digital Pathology Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact on altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Global Digital Pathology Market are:
- Perkin Elmer, Inc.
- Definiens AG
- Sectra AB
- Koninklijke Philips N.V
- GE Healthcare
- Inspirata Co.
Along with these companies, there were many other companies considered/ cited in the report while analysing the Global Digital Pathology market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Growing trend of digitalisation in the medical sector
4.1.2. Rising Incidence of Cancer
4.1.3. Increasing creativities by governments and industry players
4.1.4. Growing applications of digital pathology in drug development and companion diagnostics
4.1.5. Ease of consultation enabled by Digital Pathology
4.2. Restraints & Challenges
4.2.1. The high cost of digital pathology systems
4.2.2. Lack in reimbursement
4.2.3. Inadequate infrastructure
4.3. Opportunities
4.3.1. Disabling the deficiency of pathologists through Digital Pathology
4.3.2. Personalized medicine
4.3.3. Addition of laboratory and digital pathology systems
4.3.4. Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
5. Global Digital Pathology Market– By Type
5.1. Human pathology
5.2. Veterinary pathology
5.3. Others
6. Global Digital Pathology Market- By Product
6.1. Scanners
6.2. Software
6.3. Communication Systems
6.4. Storage Systems
6.5. Others
7. Global Digital Pathology Market– By Application
7.1. Teleconsultation
7.2. Disease Diagnosis
7.3. Drug Discovery
7.4. Training and education
7.5. Others
8. Global Digital Pathology Market-By End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Hospitals and Reference Laboratories
8.3. Academic & Research Institutes
8.4. Others
9. Global Digital Pathology Market– By Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. APAC
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia & New Zealand
9.4.5. South Korea
9.4.6. Others
9.5. South America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Others
9.6. Middle East & Africa
9.6.1. Middle East
9.6.2. Africa
10. Global Digital Pathology Market– Company Profiles
10.1. Perkin Elmer, Inc.
10.2. Definiens AG
10.3. Sectra AB
10.4. Koninklijke Philips N.V
10.5. GE Healthcare
10.6. Inspirata Co.
10.7. Ventana Medical Systems, Inc.
10.8. Leica Biosystems
10.9. 3DHistech Ltd
10.10. Hamamatsu Photonics, K.K.
10.11. Digipath Co.
10.12. Carl Zeiss AG
10.13. Olympus Corporation
10.14. Yokogawa Electronic Corporation
10.15. Quorum Technologies Inc.
11. Global Digital Pathology Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,511.39 - €7,534.18
- INR: ₹223,024.12 - ₹669,072.36
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,180.22 - £6,540.65
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Pathology is a significant field in the modern medical diagnosis and medical research, concerned mainly with the causal study of disease, whether caused by pathogens or non-infectious physiological disorder. Pathology includes the related scientific study of the disease process. Pathology plays a vital role in all aspects of medicine throughout our lives.
Global Digital Pathology Market Size & Growth:
The global digital pathology market was valued at $0.42 billion in 2019 and is estimated to reach $0.95 billion by 2025, at a CAGR of 13.4% during 2019-2025. The critical factors responsible for the growth of the global digital pathology market include growing trend of digitalisation in the medical sector, rising Incidence of cancer, increasing opportunities by governments and industry players and growing applications of digital pathology in drug development. The high cost of digital pathology systems, lack of reimbursement and inadequate infrastructure are hampering the market growth. The future scope of the global digital pathology market is disabling the deficiency of pathologists through digital pathology, personalised medicine, the addition of laboratory and digital pathology systems, integration of laboratory information systems (LIS) and digital pathology systems.
Global Digital Pathology Market Segments Share:
The global digital pathology market is segmented based on the type, product, application, end user and geography. By type, the global digital pathology market is segregated into human pathology, veterinary pathology. Human pathology is the largest market in the global digital pathology market owing to the factors like increasing adoption of the digital pathology to enhance lab efficiency and growing applications of digital pathology. Veterinary pathology is the promising segment tending towards the market growth. By product, the market is segregated into scanners, software, communication systems, storage systems. The software is expected to register the highest growth and is also largest market by product due to the availability of analytical, user-friendly and advanced functions for pathology diagnosis. By application, the market is categorised into teleconsultation, disease diagnosis, drug discovery, training and education. Tele-consultation is the largest market and is expected to register the fastest growth in the global pathology market owing to the increasing need for quality, and fast diagnosis have enhanced the utilisation of teleconsultation applications. By geography, North America is the most significant market share in the digital pathology market owing to increasing usage of digital pathology for disease diagnosis and favourable reimbursement policies in the U.S. for improving the quality of cancer diagnosis. Asia Pacific region is the fastest growing region due to the presence of a large target patient population, and booming healthcare industry is encouraging the growth of the regional market.
Global Digital Pathology Market Trends:
- Visiopharm has entered an agreement with HAMAMATSU to sell their portfolio of slide scanners, co-branded as Oncotopix® Scan, for clinical customers in Europe.
- Bayer develops companion diagnostic test for cancer patients together with Leica Biosystems.
Global Digital Pathology Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact on altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Global Digital Pathology Market are:
- Perkin Elmer, Inc.
- Definiens AG
- Sectra AB
- Koninklijke Philips N.V
- GE Healthcare
- Inspirata Co.
Along with these companies, there were many other companies considered/ cited in the report while analysing the Global Digital Pathology market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Growing trend of digitalisation in the medical sector
4.1.2. Rising Incidence of Cancer
4.1.3. Increasing creativities by governments and industry players
4.1.4. Growing applications of digital pathology in drug development and companion diagnostics
4.1.5. Ease of consultation enabled by Digital Pathology
4.2. Restraints & Challenges
4.2.1. The high cost of digital pathology systems
4.2.2. Lack in reimbursement
4.2.3. Inadequate infrastructure
4.3. Opportunities
4.3.1. Disabling the deficiency of pathologists through Digital Pathology
4.3.2. Personalized medicine
4.3.3. Addition of laboratory and digital pathology systems
4.3.4. Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
5. Global Digital Pathology Market– By Type
5.1. Human pathology
5.2. Veterinary pathology
5.3. Others
6. Global Digital Pathology Market- By Product
6.1. Scanners
6.2. Software
6.3. Communication Systems
6.4. Storage Systems
6.5. Others
7. Global Digital Pathology Market– By Application
7.1. Teleconsultation
7.2. Disease Diagnosis
7.3. Drug Discovery
7.4. Training and education
7.5. Others
8. Global Digital Pathology Market-By End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Hospitals and Reference Laboratories
8.3. Academic & Research Institutes
8.4. Others
9. Global Digital Pathology Market– By Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. APAC
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia & New Zealand
9.4.5. South Korea
9.4.6. Others
9.5. South America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Others
9.6. Middle East & Africa
9.6.1. Middle East
9.6.2. Africa
10. Global Digital Pathology Market– Company Profiles
10.1. Perkin Elmer, Inc.
10.2. Definiens AG
10.3. Sectra AB
10.4. Koninklijke Philips N.V
10.5. GE Healthcare
10.6. Inspirata Co.
10.7. Ventana Medical Systems, Inc.
10.8. Leica Biosystems
10.9. 3DHistech Ltd
10.10. Hamamatsu Photonics, K.K.
10.11. Digipath Co.
10.12. Carl Zeiss AG
10.13. Olympus Corporation
10.14. Yokogawa Electronic Corporation
10.15. Quorum Technologies Inc.
11. Global Digital Pathology Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.